#firmday 2nd oct 2014 kevan nicholson parexel and ibm - agile rpo

© 2013 IBM Corporation

Agile Talent AcquisitionDesigning and operating an RPO solution to complement the internal recruitment team

IBM and PAREXEL RPO Partnership

2nd October 2014

© 2013 IBM Corporation2

IntroductionsDavid Whittingham-Jones, RPO Sales Leader, Europe

David has 17 years recruiting experience in Sales, Solutions and Operational delivery roles. Between 2007 and 2010 David led RPO program delivery in EMEA and APAC with Microsoft and Verizon; and has gone on to lead all international relationships across our client base. Today, David leads our Sales and Solutions functions across Europe.

Kevan Nicholson, Senior Operations Manager, PAREXEL

Kevan Nicholson joined PAREXEL in June 2008, he is a seasoned Talent Acquisition Leader having worked in the clinical industry over the past 10 years and prior to this in the IT sector. Previous companies include Covance, PRA International and Parametric Technology. Kevan’s role at PAREXEL is to lead an international team of recruiters that work strategically and creatively with the business leaders to ensure they hire candidates that are the right fit for PAREXEL’s high performance culture.

Rima Haddadi, Operations Manager, IBM on behalf of PAREXEL

Rima has over 6 years’ experience in Life Sciences recruitment, initially responsible for the medical division of a recruitment agency and was a key supplier to the NHS. Rima joined IBM 2 years ago on the PAREXEL team and is responsible for the management and program success of the EMEA team (up to 20 Recruiters and Researchers). As well as providing operational guidance for the team Rima personally manages the hiring process for senior roles.


Agenda

1. IBM RPO

2. PAREXEL’s Market

3. RPO Design Priorities and Method

4. Evolving Delivery Models

5. Outcomes

6. Q&A


Our Recruiting, Behavioural Science and Technology Foundation Helps Companies Hire the Very Best People

Founded:

1987 19

Years of RPO experience

1,500+ RPO staff

Employee Population:

2,80085,000+

Annual Hires

13Global RPO Centres of Excellence

40%RPO client

engagements include multi-

region delivery

60%RPO client

engagements are multi-country

solutions

Hiring in:

80 Countries

27 yearsExperience in

Recruiting

100M+Candidates in

databases

35M+Candidates assessed annually

8M+Surveys annually

100+ Occupational Psychologists

and Researchers

11Years among

HRO Today’s top providers

60+RPO clients worldwide

IBM Kenexa Smarter Workforce: Recruitment Services


IBM RPO delivery models

Hybrid RPO Full RPO Project support

IBM manages talent sourcing and recruitment administration

IBM Role

IBM Deliverables

Length

► Requisition intake► Sourcing, screening and

shortlisting candidates► Talent market research► Administration activities

Long-term(1-5 years)

IBM manages hiring process from requisition intake through onboarding

► Sourcing and screening plus:– Hiring manager interface– Interview scheduling– Offer management– Onboarding

Long-term(1-5 years)

IBM manages a distinct hiring project

► Hybrid or Full delivery

Project-based(<1 year)


PAREXEL’s Market



Who is PAREXEL

7

• PAREXEL is one of the largest bio/pharmaceutical outsourcing organizations in the world

• The industry has evolved to a full-service industry from the earliest stages of development through clinical trials and commercialization of products

• Employ over 14,000 people in 50+ countries

• Experiencing tremendous growth (26.5%) in a highly competitive industry


BioPharmaceutical Development to Market

Discovery Development Manufacture Distribution

ClinicalTrials

Safe • Effective • Better?


Our work

Asthma | Drug: Seretide• 300 million people currently suffer from asthma • It is the most common chronic disease among children (WHO 2009)

Diabetes | Drugs: Galvus, Januvia• More than 220 million people have diabetes• Diabetes deaths are projected to double between 2005 and 2030 (WHO 2009)

HIV/AIDS | Drugs: Adefovir, Emtriva • 33.4 million people live with HIV/AIDS worldwide• An estimated 2.7 million people were newly infected with the virus in 2008 (WHO

2009)

Cardiovascular Disease | Drugs: Crestor, Tolvaptan, Zocor• Cardiovascular Diseases are the number one cause of death globally: more people

die annually from cardiovascular diseases than from any other cause (WHO 2009)

9


RPO Design Priorities and Method



Summary

Recruiting Model structure to address key business drivers:

• Deliver highly-qualified candidates in a timely manner• Leverage PAREXEL Employee Value Proposition to source and recruit

talent• Provide for a scalable solution to meet rapid increases/decreases in

demand for talent• Develop capability to provide Predictive Analytics & Measurement to the

SBUs• Maximize the impact of recruiting on corporate profitability

EMEA RPO scope:• 17 countries, approx. 600 requisitions per annum

11


Process Considerations – Multi Sourced Approach

Sourcing Screening Interview Offer Pre Hire

In House

■ Strategy Design

■ Research

■ Event Management

■ Behavior Based Interview

■ Candidate/HM Relationship Management

■ Offer Calibration

■ Verbal Offer

■ Written Offer

■ Renegotiation

■ Reference Check

Outsourced (RPO)

■ Strategy Design & Execution

■ Candidate Development

■ Networking & Competitive Sourcing

■ Resume Review

■ Phone Screen (“QIA”)

■ Competency Based Screening

■ Interview Coordination

Outsourced (TMP)

■ Event Management

■ Branding

■ Advertising

Outsourced (Other)

■ Reference Check

■ Background Investigation

■ Drug Screening


Evolving our Design

13

Senior Candidate Developer

Strategic Business

Units

Lead Recruiter

Lead Recruiter



Lead Recruiter

ResearchersCandidate Developer

KrakowBuenos

AiresCaryFriscoLondon Vizag

Resources

Institutional Expertise

Sourcing Expertise

Coordinators

Scalable Resources

PAREXEL Team

IBM Kenexa Team


How Design Impacts Group Dynamics


Strategic Business

Units

Lead Recruiter

Lead Recruiter



Lead Recruiter

Candidate Developer

Candidate Developer

Candidate Developer

Team 1 Team 2 Team 3

• Controlled program induction• Productive knowledge development• Credibility establishment• Culture and history understanding


What does this look like in operation?

The challenge:• Assignment volume forecast, 5 months:

250 requisitions• Assignment volume actual, 5 months:

595 requisitions (global)• New model launch and recruiter role

change, 11.1.2011

The response:– Increased RPO team 33%– Augmented team goal

0100200300400500600

New CandidatesChange in pipeline:


Outcomes


Results - Scalability

17

Solution able to scale to support rapidly escalating and declining demand for resources


Results – Time to Fill

18

Average Time to Hire has declined by 42% since reaching a peak of 86 days in February 2012

2014 actual metric is 49 days Time to Fill


Results – Quality of Hire

19

Hiring Manager Quality of Hire Ratings have improved each quarter

Thinking of the most recent employee that you hired, on a scale of 1 to 10 (10 being best), how would you rate his or her performance?

2014 actual metric is 8.1


Results – First Year Turnover

20

First Year Turnover has declined from more than 19% to under 13%


Key takeaways

1. Design your RPO solution to fit your organization and market

2. Find a partner willing to model and run a solution that fits your strategy

3. Ensure you and your partner leverage multiple career levels and specializations

4. Insist on a clear team development and succession plan

5. Expect your program to evolve and enjoy the ride!


Appendix

23

Key Positions Filled Regional Scope

BelgiumCanadaCzech RepublicFranceGermanyHungaryIrelandItalyLithuania NetherlandsPolandRomaniaRussiaSerbiaSpain UKUkraineUnited States

Biostatistics & Clinical ProgrammingClinical LogisticsClinical Research AssociatesConsulting and ReimbursementData ManagementClinical FeasibilityFinance Medical AffairsMedical CommunicationsMedical ImagingMedical WritingPatient and Site RecruitmentPharmacovigilanceRegulatory AffairsProject ManagementQuality and ComplianceSoftware Development and IT


Legal Disclaimer

• © IBM Corporation 2013. All Rights Reserved.• The information contained in this publication is provided for informational purposes only. While efforts were made to verify the completeness and accuracy of the information contained

in this publication, it is provided AS IS without warranty of any kind, express or implied. In addition, this information is based on IBM’s current product plans and strategy, which are subject to change by IBM without notice. IBM shall not be responsible for any damages arising out of the use of, or otherwise related to, this publication or any other materials. Nothing contained in this publication is intended to, nor shall have the effect of, creating any warranties or representations from IBM or its suppliers or licensors, or altering the terms and conditions of the applicable license agreement governing the use of IBM software.

• References in this presentation to IBM products, programs, or services do not imply that they will be available in all countries in which IBM operates. Product release dates and/or capabilities referenced in this presentation may change at any time at IBM’s sole discretion based on market opportunities or other factors, and are not intended to be a commitment to future product or feature availability in any way. Nothing contained in these materials is intended to, nor shall have the effect of, stating or implying that any activities undertaken by you will result in any specific sales, revenue growth or other results.

• If the text contains performance statistics or references to benchmarks, insert the following language; otherwise delete:Performance is based on measurements and projections using standard IBM benchmarks in a controlled environment. The actual throughput or performance that any user will experience will vary depending upon many factors, including considerations such as the amount of multiprogramming in the user's job stream, the I/O configuration, the storage configuration, and the workload processed. Therefore, no assurance can be given that an individual user will achieve results similar to those stated here.

• If the text includes any customer examples, please confirm we have prior written approval from such customer and insert the following language; otherwise delete:All customer examples described are presented as illustrations of how those customers have used IBM products and the results they may have achieved. Actual environmental costs and performance characteristics may vary by customer.

• Please review text for proper trademark attribution of IBM products. At first use, each product name must be the full name and include appropriate trademark symbols (e.g., IBM Lotus® Sametime® Unyte™). Subsequent references can drop “IBM” but should include the proper branding (e.g., Lotus Sametime Gateway, or WebSphere Application Server). Please refer to http://www.ibm.com/legal/copytrade.shtml for guidance on which trademarks require the ® or ™ symbol. Do not use abbreviations for IBM product names in your presentation. All product names must be used as adjectives rather than nouns. Please list all of the trademarks that you use in your presentation as follows; delete any not included in your presentation. IBM, the IBM logo, Lotus, Lotus Notes, Notes, Domino, Quickr, Sametime, WebSphere, UC2, PartnerWorld and Lotusphere are trademarks of International Business Machines Corporation in the United States, other countries, or both. Unyte is a trademark of WebDialogs, Inc., in the United States, other countries, or both.

• If you reference Adobe® in the text, please mark the first use and include the following; otherwise delete:Adobe, the Adobe logo, PostScript, and the PostScript logo are either registered trademarks or trademarks of Adobe Systems Incorporated in the United States, and/or other countries.

• If you reference Java™ in the text, please mark the first use and include the following; otherwise delete:Java and all Java-based trademarks are trademarks of Sun Microsystems, Inc. in the United States, other countries, or both.

• If you reference Microsoft® and/or Windows® in the text, please mark the first use and include the following, as applicable; otherwise delete:Microsoft and Windows are trademarks of Microsoft Corporation in the United States, other countries, or both.

• If you reference Intel® and/or any of the following Intel products in the text, please mark the first use and include those that you use as follows; otherwise delete:Intel, Intel Centrino, Celeron, Intel Xeon, Intel SpeedStep, Itanium, and Pentium are trademarks or registered trademarks of Intel Corporation or its subsidiaries in the United States and other countries.

• If you reference UNIX® in the text, please mark the first use and include the following; otherwise delete:UNIX is a registered trademark of The Open Group in the United States and other countries.

• If you reference Linux® in your presentation, please mark the first use and include the following; otherwise delete:Linux is a registered trademark of Linus Torvalds in the United States, other countries, or both. Other company, product, or service names may be trademarks or service marks of others.

• If the text/graphics include screenshots, no actual IBM employee names may be used (even your own), if your screenshots include fictitious company names (e.g., Renovations, Zeta Bank, Acme) please update and insert the following; otherwise delete: All references to [insert fictitious company name] refer to a fictitious company and are used for illustration purposes only.

http://www.ibm.com/legal/copytrade.shtml

#firmday 2nd oct 2014 kevan nicholson parexel and ibm - agile rpo

Recruiting & HR